Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant Application
Duke University - $82,049
$82,049.00 USD
November 2011
Preclinical Evaluation of Systemic and Direct Delivery of a PDGFR-Alpha Antibody
Doernbecher Children's Hospital - $100,000
$100,000.00 USD
November 2011
Rapid Preclinical Development of a Targeted Therapy Combination for DIPG.
St. Jude's Children's Research Hospital - $35,000
$35,000.00 USD
September 2010
PI3K signaling effectors in DIPG
Cincinnati Children's Hospital - $35,000
$35,000.00 USD
September 2010
Establishment of a pre-clinical model for pediatric glioblastoma
Cincinnati Children's Hospital - $75,000
$75,000.00 USD
March 2010
Telomerase: A Therapeutic Target in Pediatric Brain Tumors
Weill Cornell Medical College - $91,740
$91,740.00 USD
March 2010
Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.
St. Jude's Children's Research Hospital - $10,000
$10,000.00 USD
July 2009
Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.
Cincinnati Children's Hospital - $50,000
$50,000.00 USD
July 2009
National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
St. Jude's Children's Research Hospital - $50,000
$50,000.00 USD
July 2009
Phase I Study of the combination of Vandetanib and Dasatinib administered during and after radiation therapy in the children with newly diagnosed DIPG.
Cincinnati Children's Hospital - $50,000
$50,000.00 USD
September 2008
Study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
St. Jude's Children's Research Hospital - $25,000
$25,000.00 USD
September 2008
Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.
McGill University - $100,000
$100,000.00 USD
October 2024
Understanding tumor heterogeneity and characterizing treatment responses in ACVR1-mutated diffuse midline gliomas.
The Hospital For Sick Children (SickKids) – $100,000
$100,000.00 USD
November 2022
Synthetic lethality screening with methionine restriction for treatment of DIPG
The Hospital for Sick Children - $100,000
$100,000.00 USD
September 2020
Methionne Deptrivation as a Therapeutic Strategy for Diffuse Intrinsic Pontine Glioma